Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Intussusception-associated hospitalisations in Southern Germany

Abstract

The primary objective of this epidemiological surveillance study was to estimate the incidence of intussusception (IS) associated with hospitalisation in children <1, <2 and <17 years of age in Germany. We analysed primary and secondary ICD-10 discharge diagnoses for IS (K56.1) and procedure codes for desinvagination from 28 paediatric hospitals in Bavaria, Germany, to identify children hospitalised in 2005 or 2006 due to IS. A total of 518 children with an ICD-10 code for IS were reported: 123 (23.7%) of the children were <1 year of age, 267 (51.5%) were 1–3 years old and 128 (24.8%) older than 3 years of age. IS was the primary ICD-10 diagnosis in 382 (74%) children, including 231 (60%) children with a procedure code for desinvagination. In 136 (26%) children, IS was reported as a secondary ICD-10 diagnosis, including 38 (28%) with a desinvagination procedure code. The yearly incidence of IS in children <1 year of age was estimated as 72/100,000 overall and as 43/100,000 for those with an additional procedural code for desinvagination. Patients solely with an ICD-10 code for IS are often suspected cases, based on clinical presentation. The combination of the ICD-10 code for IS and a procedure code for desinvagination provides a more specific and clinically relevant case definition, thereby offering a useful tool for long-term surveillance of the incidence of IS.

This is a preview of subscription content, log in to check access.

Fig. 1

References

  1. 1.

    Benz G, Roth H, Tröger J, Daum R (1987) Intestinal invagination. Analysis of case reports in the last 45 years. Chir Pédiatr 28(3):155–157

  2. 2.

    Bines JE, Ivanoff B (2002) Acute intussusception in infants and children: incidence, clinical presentation and management: a global perspective. WHO/V&B/02.19. World Health Organisation, Department of Vaccines and Biologicals, Geneva

  3. 3.

    Bines JE, Kohl KS, Forster J, The Brighton Collaboration Intussusception Working Group et al (2004) Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis and presentation. Vaccine 22(5–6):569–574

  4. 4.

    Bines JE, Liem NT, Justice FA et al (2006) Risk factors for intussusception in infants in Vietnam and Australia: adenovirus implicated, but not Rotavirus. J Pediatr 149:452–460

  5. 5.

    Bines JE, Patel M, Parashar U (2009) Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception. J Infect Dis 200:282–289

  6. 6.

    Buettcher M, Baer G, Bonhoeffer J et al (2007) Three-year surveillance of intussusception in children in Switzerland. Pediatrics 120:473–480

  7. 7.

    CDC (1999) Withdrawal of rotavirus vaccine recommendation. MMWR 48(43):1007

  8. 8.

    Chang H-GH, Smith PF, Ackelsberg J et al (2001) Intussusception, rotavirus diarrhea and rotavirus vaccine use among children in New York State. Pediatrics 108:54–60

  9. 9.

    Chang EJ, Zangwill KM, Lee H, Ward JI (2002) Lack of association between rotavirus infection and intussusception: implications for use of attenuated rotavirus vaccines. Pediatr Infect Dis J 21(2):97–102

  10. 10.

    Chen YE, Beasley S, Grimwood K, The New Zealand Rotavirus Study Group (2005) Intussusception and rotavirus associated hospitalisation in New Zealand. Arch Dis Child 90:1077–1081

  11. 11.

    Cortese MM, Staat MA, Weinberg GA (2009) Underestimates of intussusception rates among US infants based on inpatient discharge data: implications for monitoring the safety of rotavirus vaccines. J Infect Dis 200:264–270

  12. 12.

    Deindl C, Hecker W, Löw B (1990) Invagination in childhood. Chirurg 61(9):657–661

  13. 13.

    Ein SH, Palder SB, Alton DJ, Daneman A (1995) Intussusception: toward less surgery? J Pediatr Surg 30(5):768

  14. 14.

    Gay N, Ramsay M, Waight P (1999) Rotavirus vaccination and intussusception. Lancet 354:956

  15. 15.

    Haber P, Patel M, Izurieta HS et al (2008) Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics 121:1206–1212

  16. 16.

    Huber FX, Schall R, Fritz-Krieglstein C et al (1997) ICPM-independent computer-assisted documentation concerning the new law on state care benefits—methods and results in 1995. Langenbecks Arch Chir 382:69–73

  17. 17.

    Huppertz HI, Soriano-Gabarrò M, Grimprel E (2006) Intussusception among young children in Europe. Pediatr Infect Dis J 25:S22–S29

  18. 18.

    Jakab F, Péterfai J, Verebély T et al (2007) Human astrovirus infection associated with childhood intussusception. Pediatr Int 49:103–105

  19. 19.

    Justice F, Carlin J, Bines J (2005) Changing epidemiology of intussusception in Australia. J Paediatr Child Health 41:475–478

  20. 20.

    Kramarz P, France EK, DeStefano F et al (2001) Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis J 20(4):410–416

  21. 21.

    Navarro OM, Daneman A, Chae A (2004) Intussusception: the use of delayed, repeated reduction attempts and the management of intussusceptions due to pathologic lead points in pediatric patients. Am J Roentgenol 182(5):1345

  22. 22.

    Nelson E, Tam JS, Glass RI et al (2002) Incidence of rotavirus diarrhea and intussusception in Hong Kong using a standardized hospital discharge data. Pediatr Infect Dis J 21(7):701–703

  23. 23.

    Parashar UD, Holman RC, Cummings KC et al (2000) Trends in intussusception-associated hospitalisations and deaths among US infants. Pediatrics 106:1413–1421

  24. 24.

    Patel MM, Haber P, Baggs J, Zuber P, Bines JE, Parashar UD (2009) Intussusception and rotavirus vaccination: a review of the available evidence. Expert Rev Vaccin 8(11):1555–1564

  25. 25.

    Ruiz-Palacios GM, Pérez-Schael I, Velázquez R et al (2006) Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354:11–22

  26. 26.

    Simonsen L, Viboud C, Elixhauser A et al (2005) More on RotaShield and intussusception: the role of age at the time of vaccination. J Infect Dis 192(1):36–42

  27. 27.

    Statz G, Alzen G, Heimann G (1998) Intestinal infection, the most frequent cause of invagination in childhood: results of a 10-year clinical study. Klin Pädiatr 210(2):61–64

  28. 28.

    Tate JE, Simonsen L, Viboud C et al (2008) Trends in intussusception hospitalisations among US infants, 1993-2004: implications for monitoring the safety of the new rotavirus vaccination program. Pediatrics 121(5):e1125–e1132

  29. 29.

    Vesikari T (2008) ESPID/ESPGHAN evidence-based recommendations for rotavirus vaccination in Europe. J Pediatr Gastroenterol Nutr 46(2):V–VI

  30. 30.

    Vesikari T, Karvonen AV, Majuri J et al (2006) Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children. J Infect Dis 194(3):370–376

  31. 31.

    Zanardi LR, Haber P, Mootrey GT et al (2001) Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system. Pediatrics 107:e97

Download references

Acknowledgements

We thank all the participating paediatric hospitals in Bavaria for providing data. We thank A. Köhn and I. Schicker for their organisational support. The study was supported by an unrestricted grant from GlaxoSmithKline Biologicals, Rixensart (Belgium).

Author information

Correspondence to Johannes G. Liese.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kohl, L.J., Streng, A., Grote, V. et al. Intussusception-associated hospitalisations in Southern Germany. Eur J Pediatr 169, 1487–1493 (2010). https://doi.org/10.1007/s00431-010-1248-x

Download citation

Keywords

  • Intussusception
  • Incidence
  • ICD-10
  • Surveillance
  • Desinvagination